SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is facing high volatility following a quarterly earnings report that missed profit estimates but featured raised full-year revenue guidance. The community is sharply divided, with bulls pointing to the potential of branded weight-loss partnerships and peptide initiatives, while bears emphasize margin compression and concerns over the long-term sustainability of the company's growth.

Quantum Computing, Inc. engages in developing novel algorithms and solutions utilizing quantum and quantum-inspired computing to solve difficult problems in various industries. It leverages its expertise in finance, computing, security, mathematics, and physics to develop commercial applications for the financial, security, and government sectors. The company was founded on July 25, 2001 and is headquartered in Hoboken, NJ.

Quantum Computing Inc

Quantum Computing Inc. is trending as it gains strong investor sentiment following the deployment of its Dirac-3 machine in the Quantum Corridor, fueling expectations for improved commercial revenue. Investors are closely monitoring its photonic technology, particularly its Thin-Film Lithium Niobate chips, while speculating on the stock's potential for a significant short squeeze given its high short interest and aggressive call buying.

Fundrise Innovation Fund LLC operates as a non-diversified, closed-end management investment company. It invests in growing tech companies to help them expand and generate profits. The company was founded on June 7, 2021 and is headquartered in Washington, DC.

Fundrise Innovation Fund LLC. - Common Shares of Limited Liability Company Interests

Fundrise Innovation Fund 

The Fundrise Innovation Fund is currently experiencing extreme volatility as retail traders debate whether the stock is a speculative opportunity for exposure to high-growth AI and private companies or a dangerously overvalued asset trading far above its net asset value. Community discussions are dominated by sharp disagreements over the fund's NAV, concerns regarding insider share lockups, and intense speculation about potential IPO catalysts for its major holdings like Anthropic and SpaceX.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics is currently experiencing intense market volatility as investors weigh the company's aggressive infrastructure expansion and hyperscaler demand against significant earnings misses and supply chain bottlenecks. The stock remains a major talking point within the AI optics sector, with the community actively debating whether it is a critical piece of the data center buildout or a speculative bubble facing an inevitable correction.

GSI Technology, Inc. engages in the design, development and marketing of memory products primarily for the networking, and telecommunications markets. Its product includes Static Random Access Memory, or SRAM, which incorporated in networking and telecommunications equipment, such as routers, switches, wide area network infrastructure equipment, wireless base stations and network access equipment. It also offers services to the ongoing needs of the military, industrial, test and measurement equipment, automotive and medical markets for SRAMs .The company was founded by Lee-Lean Shu and Robert Yau in March 1995 and is headquartered in Sunnyvale, CA.

GSI Technology Inc

GSI Technology is seeing significant momentum and heightened community discussion driven by its pivot toward Edge AI and its specialized Associative Processing Unit (APU) technology, which supporters argue offers efficiency advantages in defense and autonomous drone applications. However, the stock remains a source of intense debate, as skeptical traders warn of potential rug-pulls and management transparency issues, pointing to past volatility and concerns over the company's reliance on legacy SRAM products versus its unproven AI hardware.

Twin Vee PowerCats Co. engages in the design, manufacture, and sale of recreational and commercial power catamaran boats. The firm is focused on designing and developing its products under the ELECTRA Power Sports brand. It operates through the Twin Vee PowerCats and Wizz Banger, Inc. Segments. The Twin Vee PowerCats segment designs, manufactures, and sells recreational and commercial powerboats. The Wizz Banger, Inc. segment refers to a development-stage subsidiary with plans to develop an innovative online marketplace leveraging artificial intelligence (AI) to transform how customers search for and purchase recreational marine assets. The company was founded by Roger Dunshee in 1996 and is headquartered in Fort Pierce, FL.

Twin Vee PowerCats Co

Twin Vee PowerCats is trending as retail traders target its extremely low float and post-reverse-split setup for a potential short squeeze. The community is heavily focused on the high cost-to-borrow and lack of available short shares, with many drawing comparisons to previous low-float runners.

Bakkt, Inc. is building the backbone of next-generation financial infrastructure. The company provides solutions that enable institutional participation in the digital asset economy, spanning Bitcoin, tokenization, stablecoin payments, and AI-driven finance. Bakkt was founded in 2018 and is headquartered in New York, NY.

Bakkt Inc. - Ordinary Shares - Class A

Bakkt Holdings Inc

Bakkt is experiencing significant downward pressure following its recent earnings report, with the community expressing frustration over ongoing dilution and a perceived lack of meaningful progress on new partnerships or revenue growth. Despite the bearish sentiment and recent losses, some investors remain focused on potential long-term catalysts, such as the Clarity Act and the integration of the Distributed Technologies Research acquisition to strengthen the company's settlement infrastructure.

First Majestic Silver Corp. engages in the production, development, exploration and acquisition of mineral properties. It owns and operates producing mines in México including the La Encantada Silver Mine, La Parrilla Silver Mine, San Martin Silver Mine, La Guitarra Silver Mine, Del Toro Silver Mine, Santa Elena Silver & Gold Mine, and San Dimas Silver & Gold Mine. The company was founded by Keith Neumeyer on September 26, 1979 and is headquartered in Vancouver, Canada.

First Majestic Silver Corporation

First Majestic Silver is trending as investors monitor momentum-building silver prices and high anticipation for upcoming earnings, with the community actively debating whether the stock is primed for a breakout or vulnerable to further algorithmic volatility. Discussions remain focused on the stock's leverage to silver spot prices and ongoing supply-side concerns, while traders weigh the impact of recent consolidation patterns ahead of corporate results.

Destiny Tech100, Inc. operates as a non-diversified, closed-end management investment company. The company was founded on November 18, 2020 and is headquartered in Austin, TX.

Destiny Tech100 Inc

DESTINY TECH 100 INC

Destiny Tech 100 is drawing intense attention due to its exposure to major private AI and space firms, particularly Anthropic and SpaceX, ahead of highly anticipated IPOs. The community is actively debating the fund's premium to net asset value, concerns over indirect holding structures, and the potential for a short squeeze as traders weigh dilution risks against the massive growth potential of the underlying portfolio.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines is capturing intense market attention as investors position themselves ahead of the upcoming Q1 earnings release and critical NASA contract announcements. The community is actively debating the stock's growth trajectory, with bullish sentiment heavily fueled by the company's expanding backlog and industry anticipation surrounding a potential SpaceX IPO.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$ADMA I believe ADMA is exploiting the current lowish share valuation to gulp as many outstanding shares as they possibly can.

They know the following things-&gt;

A)Based on ASCENIV growth, even if they maintain secondary items growth relatively flat, they are going to increase margins by 50-60% higher than they used to be.

B)If ASCENIV keeps growing nicely, we are talking about $700-750M in revenue by 2027, with excellent margins and cash cow-level net income. Possibly around a $10B market cap based on that -&gt; with dozens of millions fewer shares outstanding.

That&#39;s all, folks -&gt; one can argue that if ASCENIV does not do what it is expected to do, then ADMA will not deliver. Same goes for Corcept without Korlym, Xeris without Recorlev, and Nvidia without AI:)

But if you believe, as ADMA does, that ASCENIV can keep growing nicely (let&#39;s say 25-30% this year &amp; next year, while keeping at least the same revenue from secondary products), you could possibly see ~$50p/s along 2027.

Tyler

The Icc

Shanae Gupta

Candace V

StockTwits For Android 

Adma Biologics Inc

 I believe ADMA is exploiting the current lowish share valuation to gulp as many outstanding shares as they possibly can.

They know the following things->

A)Based on ASCENIV growth, even if they maintain secondary items growth relatively flat, they are going to increase margins by 50-60% higher than they used to be.

B)If ASCENIV keeps growing nicely, we are talking about $700-750M in revenue by 2027, with excellent margins and cash cow-level net income. Possibly around a $10B market cap based on that -> with dozens of millions fewer shares outstanding.

That's all, folks -> one can argue that if ASCENIV does not do what it is expected to do, then ADMA will not deliver. Same goes for Corcept without Korlym, Xeris without Recorlev, and Nvidia without AI:)

But if you believe, as ADMA does, that ASCENIV can keep growing nicely (let's say 25-30% this year & next year, while keeping at least the same revenue from secondary products), you could possibly see ~$50p/s along 2027.

Alon Rosenzweig

@Alon_R I sold awhile back. Was a good run for me but I periodically check in here to see how it’s doing. I think the market is worried that the asceniv numbers may be the result of some of the same channel issues that the Bivigam figures (and short report) imply together. Which would mean that if asceniv keeps doing well, it will disprove that theory. I agree Bivigam is a small fry money wise compared to asceniv.

StockTwits for iOS

 I sold awhile back. Was a good run for me but I periodically check in here to see how it’s doing. I think the market is worried that the asceniv numbers may be the result of some of the same channel issues that the Bivigam figures (and short report) imply together. Which would mean that if asceniv keeps doing well, it will disprove that theory. I agree Bivigam is a small fry money wise compared to asceniv.

@justpassingthrough_ It&#39;s easy to assess it-&gt;

ASCENSIV is doing extremely well YoY + working on around 75-85% margins.

You are not doing 75-85% margins, if you are not a specialty treatment as ASCENIV, you are doing ~40-55%. 

That&#39;s how you assees it. As long as ASCENIV working with high margins &amp; grow strongly, it means the reality will be shaped about as I&#39;ve described above. 

And vice versa of course(but meanwhile the margins are high as well as the demand for ASCENIV).

That&#39;s the focal point of course:)

 It's easy to assess it->

ASCENSIV is doing extremely well YoY + working on around 75-85% margins.

You are not doing 75-85% margins, if you are not a specialty treatment as ASCENIV, you are doing ~40-55%. 

That's how you assees it. As long as ASCENIV working with high margins & grow strongly, it means the reality will be shaped about as I've described above. 

And vice versa of course(but meanwhile the margins are high as well as the demand for ASCENIV).

That's the focal point of course:)

@Alon_R @justpassingthrough_ but QoQ it was flat… 🤔

babette

@BabetteCH @justpassingthrough_

That&#39;s why you are calculating YoY growth-&gt;
ASCENSIV Q1 2026 +28% better than Q1 2025

Take in mind also -&gt; ADMA reaffirmed strong forward expectations, and company-wide margins actually expanded sharply in Q1 2026, suggesting ASCENIV mix remained very favorable.

So if the growth will keep on being 25-30% also for the next quarters, ADMA may be in it best financial position ever(and it would be very beneficial for shareholders, especially while they are also reducing share count). 

That&#39;s why I&#39;ll carefully track it.



That's why you are calculating YoY growth->
ASCENSIV Q1 2026 +28% better than Q1 2025

Take in mind also -> ADMA reaffirmed strong forward expectations, and company-wide margins actually expanded sharply in Q1 2026, suggesting ASCENIV mix remained very favorable.

So if the growth will keep on being 25-30% also for the next quarters, ADMA may be in it best financial position ever(and it would be very beneficial for shareholders, especially while they are also reducing share count). 

That's why I'll carefully track it.

@Alon_R I completely agree with you. I think this played out how they planned and it’s an opportunity to execute their share repurchase plan at much lower prices.

 I completely agree with you. I think this played out how they planned and it’s an opportunity to execute their share repurchase plan at much lower prices.

Jonathan

@T00thDr88 We will be much wiser during Q2 Review -&gt; if the storyline keep on being ASCENIV strong YoY growth with high margins + significant reduction of Shares outstanding + secondary items are flat or beginning to improve, so everything is according the plan.

 We will be much wiser during Q2 Review -> if the storyline keep on being ASCENIV strong YoY growth with high margins + significant reduction of Shares outstanding + secondary items are flat or beginning to improve, so everything is according the plan.

@Alon_R @BabetteCH @justpassingthrough_ they did $362M of Asceniv revenue in 2025.  Look it up in the 10K.  That’s a little over $90M run rate.  Q1 2026 was $97M, and they said that was 28% yoy growth.  That implies $76M of revenue Q1 LY, which leaves Q2-Q4 total of $286M.  That’s a run rate of $95M.  It’s not growing like you think.  The market can figure it out.  The growth story is over

 they did $362M of Asceniv revenue in 2025.  Look it up in the 10K.  That’s a little over $90M run rate.  Q1 2026 was $97M, and they said that was 28% yoy growth.  That implies $76M of revenue Q1 LY, which leaves Q2-Q4 total of $286M.  That’s a run rate of $95M.  It’s not growing like you think.  The market can figure it out.  The growth story is over

Jeremy

@jdubs66 @justpassingthrough_ @BabetteCH It&#39;s very simply as following-&gt;

ASCENIV Q1 2025 -&gt; ~$76M
ASCENIV Q1 2026 -&gt; $97.5M
-&gt; Just over 28% YoY growth (with strong margins)

What would validate that growth trajectory -&gt;
ASCENIV Q2 2025 -&gt; ~$85M
If ASCENIV Q2 2026 comes in at ~$109M, alongside strong margins and a reduction in shares outstanding, then we are clearly on the right trajectory toward the best version ADMA can become 👍

If, let&#39;s say, we see only ~$98M (~15% YoY growth) and/or materially lower ASCENIV margins, then the trajectory would be disappointing.

That&#39;s all, not too complicated over here:)

Mike C

 It's very simply as following->

ASCENIV Q1 2025 -> ~$76M
ASCENIV Q1 2026 -> $97.5M
-> Just over 28% YoY growth (with strong margins)

What would validate that growth trajectory ->
ASCENIV Q2 2025 -> ~$85M
If ASCENIV Q2 2026 comes in at ~$109M, alongside strong margins and a reduction in shares outstanding, then we are clearly on the right trajectory toward the best version ADMA can become 👍

If, let's say, we see only ~$98M (~15% YoY growth) and/or materially lower ASCENIV margins, then the trajectory would be disappointing.

That's all, not too complicated over here:)

@Alon_R @T00thDr88 
 Want to see what pediatric approval does to the growth picture 

Will reassess then

 
 Want to see what pediatric approval does to the growth picture 

Will reassess then

@USMAgrad @T00thDr88 potentially, i believe it would lead to gradual growth. Mid single digit within the first year. And somewhere around 10-20% within 2-4 years.

It&#39;s indeed very important, because it may assist to validate the growth trajectory we need during next couple of years, alongside the buyback. 

Going to be interesting and hopefully entertaining also:)

 potentially, i believe it would lead to gradual growth. Mid single digit within the first year. And somewhere around 10-20% within 2-4 years.

It's indeed very important, because it may assist to validate the growth trajectory we need during next couple of years, alongside the buyback. 

Going to be interesting and hopefully entertaining also:)